Recommendations of the Romanian Society of Rheumatology regarding the management of patients with rheumatic diseases in the context of the SARS-CoV-2 pandemic
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is responsible for the current pandemic, causing so far over 100.000 cases and more than 4500 deaths in Romania. Clinical manifestations are variable, ranging from mild forms (fever, dry cough, dyspnea, tachypnea, asthenia, myalgia) to sev...
Main Authors: | Catalin Codreanu, Ruxandra Ionescu, Denisa Predeteanu, Elena Rezus, Magda Parvu, Corina Mogosan, Claudiu C. Popescu, Simona Rednic |
---|---|
Format: | Article |
Language: | English |
Published: |
Amaltea Medical Publishing House
2020-09-01
|
Series: | Romanian Journal of Rheumatology |
Subjects: | |
Online Access: | https://rjr.com.ro/articles/2020.3/RJR_2020_3_Art-01.pdf |
Similar Items
-
Biosimilars in rheumatoid arthritis in 2022 – data from the Romanian Registry of Rheumatic Diseases
by: Horatiu Popoviciu, et al.
Published: (2023-09-01) -
Data from the Romanian Registry of Rheumatic Diseases (RRBR) for patients with axial spondyloarthritis treated with biologic disease-modifying anti-rheumatic drugs (bDMARDs) during 2019
by: Ruxandra Ionescu, et al.
Published: (2020-03-01) -
Adverse events from the Romanian Registry of Rheumatic Diseases in patients treated with biologic and targeted synthetic disease-modifying anti-rheumatic drugs during 2019
by: Corina Mogosan, et al.
Published: (2020-03-01) -
Data from the Romanian Registry of Rheumatic Diseases for patients with psoriatic arthritis treated with biologic disease-modifying anti-rheumatic drugs during 2019
by: Andra Balanescu, et al.
Published: (2020-06-01) -
Data from the Romanian Registry of Rheumatic Diseases for patients with rheumatoid arthritis treated with biologic and targeted synthetic disease-modifying anti-rheumatic drugs during 2019
by: Catalin Codreanu, et al.
Published: (2020-03-01)